In the neurological disorder amyotrophic lateral sclerosis (ALS), increased RNA editing within an intron of the solute carrier family 1 member 2 (SLC1A2) glutamate transporter creates a cryptic PAS resulting in intron retention with termination of transcription transcripts [212]. The gene discussed is SLC1A2; the disease is amyotrophic lateral sclerosis.